相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk factors for linezolid-induced thrombocytopenia in patients without haemato-oncologic diseases
Go Wun Choi et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study
Hyung-Sook Kim et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety
Ryan L. Crass et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients
Piergiorgio Cojutti et al.
CLINICAL PHARMACOKINETICS (2018)
Systematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact
Alicia Galar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
Federico Pea et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients
Yasuhiro Tsuji et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Predictors of Inadequate Linezolid Concentrations after Standard Dosing in Critically Ill Patients
Max Taubert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Therapeutic drug monitoring in the era of precision medicine: opportunities!
Serge Cremers et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Risk factors associated with high linezolid trough plasma concentrations
L. Morata et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Therapeutic drug monitoring in the past 40 years of the Journal of Antimicrobial Chemotherapy
David Reeves et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis
Akosua Adom Agyeman et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2016)
Linezolid underexposure in a patient co-treated with venlafaxine
Piergiorgio Cojutti et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation
Piergiorgio Cojutti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid
Lauren M. Boak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight
Takashi Niwa et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients
H. -Y. Dong et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Clinical experience with linezolid for the treatment of orthopaedic implant infections
Laura Morata et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study
Michael Zoller et al.
CRITICAL CARE (2014)
Risk Factors for a Low Linezolid Trough Plasma Concentration in Acute Infections
Laura Morata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria
Javier Cobo et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia
Yoko Nukui et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Successful Long-Term Treatment of Cerebral Nocardiosis with Unexpectedly Low Doses of Linezolid in an Immunocompromised Patient Receiving Complex Polytherapy
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Therapeutic drug monitoring of antimicrobials
Jason A. Roberts et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Risk Factors for Thrombocytopenia in Adult Chinese Patients Receiving Linezolid Therapy
Chao Chen et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2012)
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
Federico Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Myungsun Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy
Yoshiko Takahashi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2011)
Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction
Kazuaki Matsumoto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Linezolid: a review of safety and tolerability
Donald C. Vinh et al.
JOURNAL OF INFECTION (2009)
Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections
A. Soriano et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Linezolid:: low pre-treatment platelet values could increase the risk of thrombocytopenia
S Grau et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: Comparative analysis of linezolid and vancomycin use
SA Nasraway et al.
CLINICAL INFECTIOUS DISEASES (2003)
Linezolid for the treatment of multidrug-resistant, gram-positive infections: Experience from a compassionate-use program
MC Birmingham et al.
CLINICAL INFECTIOUS DISEASES (2003)
Hematologic effects of linezolid: Summary of clinical experience
SL Gerson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Thrombocytopenia associated with linezolid therapy
K Attassi et al.
CLINICAL INFECTIOUS DISEASES (2002)
Linezolid - A review of its use in the management of serious Gram-positive infections
CM Perry et al.
DRUGS (2001)
分享论文
